Home › Trial NCT02969031
Improving Communication Between Cancer Patients & Oncologists
- Trial IDNCT02969031
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorDana-Farber Cancer Institute
- Enrollment148
- Start date2017-02-14
- ConditionsCancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.